Turnaround

The pharmaceutical firm Organon & Co. is confronting its most severe corporate challenge to date following the discovery of manipulated...

Semler Scientific finds itself navigating treacherous waters as a potential rescue acquisition and substantial Bitcoin holdings fail to stem mounting...

Pharmaceutical giant Bristol-Myers Squibb has demonstrated a remarkable turnaround, with its latest quarterly report exceeding investor expectations through unexpectedly robust...

PDS Biotechnology Corp has taken a decisive step in its regulatory strategy, potentially altering the trajectory for its lead immunotherapy...

The global logistics leader has jolted financial markets with quarterly results that demolished Wall Street's projections. While the broader shipping...

Chinese electric vehicle manufacturer BYD is confronting significant financial challenges, marked by a sharp decline in quarterly profits and the...

In a bold strategic pivot, UnitedHealth Group is deliberately planning to reduce its Medicare Advantage membership by approximately one million...

The investment case for Nestlé, once considered a bastion of stability and reliable dividends, is showing significant cracks. The Swiss...

The final chapter appears to be unfolding for Meyer Burger Technology AG, with the company's shares signaling an irreversible breakdown....

Beyond Meat's stock experienced a severe downturn on Thursday, plunging more than 10% after the company finalized a debt restructuring...